Showing results (71-80 of 91) with videos related to
Sort By:
Pageof 10
Journal of Lipid Research|June 29, 2015
The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory propertiesAnna Schwendeman, Denis O Sviridov, Wenmin Yuan, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 22, 2019
Recombinant LCAT (Lecithin:Cholesterol Acyltransferase) Rescues Defective HDL (High-Density Lipoprotein)-Mediated Endothelial Protection in Acute Coronary SyndromeAlice Ossoli, Sara Simonelli, Marisa Varrenti, et al.European Journal of Preventive Cardiology|February 6, 2020
Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learningAna Pina, Saga Helgadottir, Rosellina Margherita Mancina, et al.Plos One|March 17, 2020
The PPAR pan-agonist tetradecylthioacetic acid promotes redistribution of plasma cholesterol towards large HDLThomas Lundåsen, Matteo Pedrelli, Bodil Bjørndal, et al.Nutrition Journal|September 11, 2019
Correction to: Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled studyMassimiliano Ruscica, Chiara Pavanello, Sara Gandini, et al.Alzheimer'S Research & Therapy|May 20, 2023
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's diseaseMarta Turri, Elisa Conti, Chiara Pavanello, et al.Nutrition Journal|February 24, 2019
Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled studyMassimiliano Ruscica, Chiara Pavanello, Sara Gandini, et al.Circulation|May 12, 2018
Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With AtherosclerosisFederico Oldoni, Damiano Baldassarre, Samuela Castelnuovo, et al.Frontiers in Genetics|September 8, 2022
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide StudyLaura D'Erasmo, Antonina Giammanco, Patrizia Suppressa, et al.Frontiers in Molecular Biosciences|August 5, 2022
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluationMarcella Palumbo, Antonina Giammanco, Francesco Purrello, et al.Pageof 10